Funded Startups in Westminster
Among the 10 most recent funded entries for Westminster, the largest disclosed round is Clever Care Health Plan Inc.
Among the 10 most recent funded entries for Westminster, the largest disclosed round is Clever Care Health Plan Inc. at $71M (2021-09-22). That $71M figure is the only disclosed amount above $50M, while the next-highest disclosed rounds sit far lower (e.g., TriSalus Life Sciences at $24M on 2022-11-09 and Cerapedics at $25M on 2022-03-07), creating a clear size outlier in the older end of the window. Dates cluster in waves: three disclosed/dated rounds fall in early 2022–early 2023 (iYOTAH Solutions $3M on 2024-02-05 aside, the most evident concentration is 2022-03-07 through 2022-11-09 across TriSalus and two other life-science names), and the list also spans a near-term edge from 2025-11-09 (Endolith) through 2026-03-04 (BioLargo). Sector-wise, biotechnology appears repeatedly (BioLargo, Endolith, TriSalus Life Sciences, Cerapedics), and stage labeling is incomplete: 3 of 10 rows carry “undisclosed” amounts and 3 of 10 use “Series Unknown” classifications.
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Westminster list, and how does it compare to the other disclosed amounts?
Clever Care Health Plan Inc. posted the largest disclosed amount at $71M on 2021-09-22. No other disclosed round in the 10 rows clears $50M; the next-highest disclosed amounts are $25M (Cerapedics, 2022-03-07) and $24M (TriSalus Life Sciences, 2022-11-09).
Are there visible clusters in timing among the most recent rounds?
Yes, multiple life-science funding events land within a relatively tight 2022 window: Cerapedics ($25M on 2022-03-07), Flagship Biosciences ($15M on 2022-09-09), and TriSalus Life Sciences ($24M on 2022-11-09). Separately, the most recent edge runs from 2025-11-09 (Endolith, amount undisclosed) to 2026-03-04 (BioLargo, $890K).
Do specific sectors appear more than once in these Westminster entries?
Biotechnology shows up in 4 of the 10 rows: BioLargo (Natural Resources), Endolith (Biotechnology), TriSalus Life Sciences (Biotechnology), and Cerapedics (Biotechnology). Health care is also repeated across entries such as StrideTech Medical (Seed, amount undisclosed) on 2025-08-11 and Nurse Lynx (Pre-Seed, $30K) on 2025-02-13.
How much of the list is hard to value because amounts or stages are not disclosed?
3 of 10 rows list “undisclosed” amounts (Endolith on 2025-11-09, StrideTech Medical on 2025-08-11, and Transitions Healthcare on 2023-06-06). In parallel, 3 of 10 rows use a “Series Unknown” classification (BioLargo on 2026-03-04, Transitions Healthcare on 2023-06-06, and Flagship Biosciences shown as “Venture - Series Unknown” on 2022-09-09).
Are there outliers in disclosed amounts, either very small or unusually large?
The smallest disclosed amount in the set is Nurse Lynx at $30K (2025-02-13). At the other end, Clever Care Health Plan Inc.’s $71M (2021-09-22) is a clear magnitude step above the rest of the disclosed amounts, with the next-largest disclosed rounds clustering around the $15M–$25M range (e.g., Cerapedics $25M, TriSalus $24M, Flagship $15M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.